Literature DB >> 16829470

Applications of MRS in the evaluation of focal malignant brain lesions.

S Delorme1, M-A Weber.   

Abstract

Magnetic resonance spectroscopy (MRS) has clinically been most extensively used for assessing brain disorders, particularly tumors. With 1-H spectroscopy at intermediate echo times, resonances from choline, creatine, N-acetyl-aspartate (NAA), lactate, and free fatty acids can be resolved well enough to assist in diagnosis under routine conditions. Generally, an increased concentration of choline is found in all primary and secondary brain tumors, and the degree of increase correlates with the degree of anaplasia. Further indicators of anaplasia are the presence of lactate, indicating hypoxia, and of fatty acids, indicating necrosis. According to literature, the sensitivity of a combination of proton spectroscopy with contrast-enhanced dynamic susceptibility-weighted imaging for high-grade components in gliomas is better than conventional contrast-enhanced imaging alone. Today, proton spectroscopy is clearly indicated for differentiating radiation-induced damage from recurrences of irradiated brain tumors.

Entities:  

Mesh:

Year:  2006        PMID: 16829470      PMCID: PMC1693767          DOI: 10.1102/1470-7330.2006.0015

Source DB:  PubMed          Journal:  Cancer Imaging        ISSN: 1470-7330            Impact factor:   3.909


  6 in total

1.  [Magnetic resonance imaging spectroscopy. Part 1: Basics].

Authors:  P Bachert; L Schröder
Journal:  Radiologe       Date:  2003-12       Impact factor: 0.635

2.  [Magnetic resonance spectroscopy. Part 2: Application in diagnosis and clinical research].

Authors:  P Bachert; M P Lichy
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

Review 3.  MR spectroscopy of brain tumors.

Authors:  Meng Law
Journal:  Top Magn Reson Imaging       Date:  2004-10

4.  Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.

Authors:  M Fuss; F Wenz; M Essig; M Muenter; J Debus; T S Herman; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

5.  Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy.

Authors:  H P Schlemmer; P Bachert; K K Herfarth; I Zuna; J Debus; G van Kaick
Journal:  AJNR Am J Neuroradiol       Date:  2001-08       Impact factor: 3.825

6.  Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Authors:  Meng Law; Stanley Yang; Hao Wang; James S Babb; Glyn Johnson; Soonmee Cha; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2003 Nov-Dec       Impact factor: 3.825

  6 in total
  7 in total

Review 1.  Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies.

Authors:  Nishant Verma; Matthew C Cowperthwaite; Mark G Burnett; Mia K Markey
Journal:  Neuro Oncol       Date:  2013-01-16       Impact factor: 12.300

2.  A semiadiabatic spectral-spatial spectroscopic imaging (SASSI) sequence for improved high-field MR spectroscopic imaging.

Authors:  Rebecca E Feldman; Priti Balchandani
Journal:  Magn Reson Med       Date:  2015-10-31       Impact factor: 4.668

3.  In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.

Authors:  F Russo; S Mazzetti; G Grignani; G De Rosa; M Aglietta; G C Anselmetti; M Stasi; D Regge
Journal:  Eur Radiol       Date:  2011-12-04       Impact factor: 5.315

4.  Association of Radiomics and Metabolic Tumor Volumes in Radiation Treatment of Glioblastoma Multiforme.

Authors:  Christopher J Lopez; Natalya Nagornaya; Nestor A Parra; Deukwoo Kwon; Fazilat Ishkanian; Arnold M Markoe; Andrew Maudsley; Radka Stoyanova
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-15       Impact factor: 7.038

5.  Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy.

Authors:  Pedram Tabatabaei; Per Bergström; Roger Henriksson; A Tommy Bergenheim
Journal:  J Neurooncol       Date:  2008-06-19       Impact factor: 4.130

6.  Cerebral Lipid Accumulation Detected by MRS in a Child with Carnitine Palmitoyltransferase 2 Deficiency: A Case Report and Review of the Literature on Genetic Etiologies of Lipid Peaks on MRS.

Authors:  Carlos R Ferreira; Molly H Silber; Taeun Chang; Jonathan G Murnick; Brian Kirmse
Journal:  JIMD Rep       Date:  2015-11-05

Review 7.  Pseudoprogression in Glioblastoma: Role of Metabolic and Functional MRI-Systematic Review.

Authors:  Ingrid Sidibe; Fatima Tensaouti; Margaux Roques; Elizabeth Cohen-Jonathan-Moyal; Anne Laprie
Journal:  Biomedicines       Date:  2022-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.